232 related articles for article (PubMed ID: 22677142)
1. Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.
Reyes BA; Szot P; Sikkema C; Cathel AM; Kirby LG; Van Bockstaele EJ
Exp Neurol; 2012 Aug; 236(2):327-35. PubMed ID: 22677142
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex.
Cathel AM; Reyes BA; Wang Q; Palma J; Mackie K; Van Bockstaele EJ; Kirby LG
Eur J Neurosci; 2014 Oct; 40(8):3202-14. PubMed ID: 25131562
[TBL] [Abstract][Full Text] [Related]
3. Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.
Reyes BAS; Carvalho AF; Szot P; Kalamarides DJ; Wang Q; Kirby LG; Van Bockstaele EJ
Exp Neurol; 2017 Jun; 292():179-192. PubMed ID: 28341460
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid modulation of cortical adrenergic receptors and transporters.
Reyes BA; Rosario JC; Piana PM; Van Bockstaele EJ
J Neurosci Res; 2009 Dec; 87(16):3671-8. PubMed ID: 19533736
[TBL] [Abstract][Full Text] [Related]
5. Modulating the modulators: interaction of brain norepinephrine and cannabinoids in stress.
Morilak DA
Exp Neurol; 2012 Dec; 238(2):145-8. PubMed ID: 22981451
[No Abstract] [Full Text] [Related]
6. Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult rats.
Carvalho AF; Reyes BA; Ramalhosa F; Sousa N; Van Bockstaele EJ
Brain Struct Funct; 2016 Jan; 221(1):407-19. PubMed ID: 25348266
[TBL] [Abstract][Full Text] [Related]
7. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex.
Page ME; Oropeza VC; Van Bockstaele EJ
Neurosci Lett; 2008 Jan; 431(1):1-5. PubMed ID: 18055114
[TBL] [Abstract][Full Text] [Related]
8. Repeated cannabinoid administration increases indices of noradrenergic activity in rats.
Page ME; Oropeza VC; Sparks SE; Qian Y; Menko AS; Van Bockstaele EJ
Pharmacol Biochem Behav; 2007 Jan; 86(1):162-8. PubMed ID: 17275893
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex.
Oropeza VC; Page ME; Van Bockstaele EJ
Brain Res; 2005 Jun; 1046(1-2):45-54. PubMed ID: 15927549
[TBL] [Abstract][Full Text] [Related]
12. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
13. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat.
Verrico CD; Jentsch JD; Dazzi L; Roth RH
Synapse; 2003 Jun; 48(4):178-83. PubMed ID: 12687636
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
Ganon-Elazar E; Akirav I
Neuropsychopharmacology; 2012 Jan; 37(2):456-66. PubMed ID: 21918506
[TBL] [Abstract][Full Text] [Related]
15. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat.
Ji XH; Ji JZ; Zhang H; Li BM
Neuropsychopharmacology; 2008 Aug; 33(9):2263-71. PubMed ID: 17957212
[TBL] [Abstract][Full Text] [Related]
17. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
Diana M; Melis M; Gessa GL
Eur J Neurosci; 1998 Sep; 10(9):2825-30. PubMed ID: 9758152
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
Yoon MH; Choi JI
Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
[TBL] [Abstract][Full Text] [Related]
19. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.
Verrico CD; Jentsch JD; Roth RH
Synapse; 2003 Jul; 49(1):61-6. PubMed ID: 12710016
[TBL] [Abstract][Full Text] [Related]
20. Chronic cannabinoid administration in vivo compromises extinction of fear memory.
Lin HC; Mao SC; Chen PS; Gean PW
Learn Mem; 2008 Dec; 15(12):876-84. PubMed ID: 19050159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
